VisEn Medical Develops New Light Based Diagnostics
Technology that enables the fast and sensitive detection of biological and disease specific markers in live tissue is a major need in the diagnostic field. […]
Technology that enables the fast and sensitive detection of biological and disease specific markers in live tissue is a major need in the diagnostic field. […]
OneMedForum NY 2011, to be held June 23 -24, has added new members to the Advisory Board and selected an initial group of “discovery” lesser known companies with terrific growth potential.
Antibody based diagnostics and therapeutics represent a major medical advance as they respectively identify diseases with high specificity and preclude systemic side effects by recognizing […]
The streamlining of advanced molecular diagnostics, particularly in genetics, is essential for expanding the use of the most cutting-edge technology throughout the healthcare industry. PlexPress […]
Identification and detection of new biomarkers that identify the beginning stages of diseases is critical for achieving successful medical treatment. EDP Biotech Corporation is a […]
MTM Laboratories has developed a proprietary technological platform that has identified a novel biomarker that serves for the early detection of cervical cancer.
Anavex Life Sciences recently announced that its clinical trial application for ANAVEX 2-73, the company’s lead compound for Alzheimer’s disease, has been approved by the German regulatory health authority.
A new non-surgical, tissue-preserving therapeutic procedure is being developed to more effectively remove HPV infection and treat precursors of cervical cancer.
Neo Matrix is a medical devices company that has developed a novel diagnostic test to determine breast cancer risk. The company’s test uses breast fluid […]
RealBio’s technology allows cells grown in a laboratory setting to develop as they would in a normal human body.
Copyright © 2025 | WordPress Theme by MH Themes